Single-Agent Investigational Therapies for Myeloproliferative Neoplasms

A key opinion leader details the single-agent therapies currently being investigated for the treatment of myeloproliferative neoplasms.

Related Videos
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Aaron Gerds, MD, MS, an expert on myelofibrosis
Stephen Oh, MD, PhD, an expert on myelofibrosis
Stephen Oh, MD, PhD, an expert on myelofibrosis
Stephen Oh, MD, PhD, an expert on myelofibrosis